Katherine Elizabeth Pankratz

Works (2)

Updated: April 5th, 2024 10:59

2021 journal article

Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety


By: K. Pankratz n, J. Korman, C. Emke n, B. Johnson n, E. Griffith n & M. Gruen n

author keywords: dog; pulsed electro-magnetic field (PEMF); behavior; fear; separation distress; separation-related behaviors
TL;DR: This study supports the efficacy and safety of this PEMF device for treatment of SA in dogs and assesses its impact on other anxieties or combination of anxiety disorders in dogs. (via Semantic Scholar)
Sources: Web Of Science, NC State University Libraries
Added: January 18, 2022

2018 journal article

Use of single-dose oral gabapentin to attenuate fear responses in cage-trap confined community cats: a double-blind, placebo-controlled field trial


By: K. Pankratz n, K. Ferris n, E. Griffith n & B. Sherman n

MeSH headings : Analgesics / administration & dosage; Animals; Behavior, Animal / drug effects; Cats; Cyclohexanecarboxylic Acids / administration & dosage; Double-Blind Method; Fear; Female; Gabapentin / administration & dosage; Male; Physical Examination / veterinary; Random Allocation
TL;DR: This study supports the hypothesis that 50 mg or 100 mg gabapentin reduces fear responses in confined community cats without measurable sedation over 3 h post-administration vs placebo, and Gabapentin treatment was well tolerated in this population of cats. (via Semantic Scholar)
Source: Web Of Science
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.